Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathies.

Roberta Palla, Carla Valsecchi, Marta Baietta, M Spreafico, Raimondo De Cristofaro, Flora Peyvandi

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

23 Citazioni (Scopus)


The mechanistic observations on the role of von Willebrand factor (VWF), ADAMTS13 and their interactions in the pathophysiology of thrombotic microangiopathies (TMAs), and in particular of thrombotic thrombocytopenic purpura (TTP), have recently yielded a proliferation of assays for the measurement of ADAMTS13 activity. These assays are generally based upon the cleavage by plasma ADAMTS13 of full-length VWF or synthetic VWF peptides (A2 domain, 73aa- or 78aa- fragment), followed by the direct or indirect detection of VWF cleavage products (1). The assays based on full-length VWF are sensitive (3 6% of ADAMTS13 activity) and quite reproducible but timeconsuming (2 3 days) and performed in non-physiological conditions that require the use of denaturing agents to promote the susceptibility of full-length VWF to cleavage. On the other hand, the assays based on VWF peptides are very sensitive (1 3% of ADAMTS13 activity), reproducible, easy, rapid (1 4 hours), and performed in the absence of denaturing agents, but they use non-physiologic substrates.
Lingua originaleEnglish
pagine (da-a)381-385
Numero di pagine5
RivistaThrombosis and Haemostasis
Stato di pubblicazionePubblicato - 2010


  • ADAMTS13
  • Thrombotic microangiopathy


Entra nei temi di ricerca di 'Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathies.'. Insieme formano una fingerprint unica.

Cita questo